nach oben

Erschienen in:

28.08.2020 | Review

Cardiovascular risk assessment in patients with rheumatoid arthritis using carotid ultrasound B-mode imaging

verfasst von: Ankush D. Jamthikar, Deep Gupta, Anudeep Puvvula, Amer M. Johri, Narendra N. Khanna, Luca Saba, Sophie Mavrogeni, John R. Laird, Gyan Pareek, Martin Miner, Petros P. Sfikakis, Athanasios Protogerou, George D. Kitas, Raghu Kolluri, Aditya M. Sharma, Vijay Viswanathan, Vijay S. Rathore, Jasjit S. Suri

Erschienen in: Rheumatology International | Ausgabe 12/2020

Einloggen, um Zugang zu erhalten

Abstract

Rheumatoid arthritis (RA) is a systemic chronic inflammatory disease that affects synovial joints and has various extra-articular manifestations, including atherosclerotic cardiovascular disease (CVD). Patients with RA experience a higher risk of CVD, leading to increased morbidity and mortality. Inflammation is a common phenomenon in RA and CVD. The pathophysiological association between these diseases is still not clear, and, thus, the risk assessment and detection of CVD in such patients is of clinical importance. Recently, artificial intelligence (AI) has gained prominence in advancing healthcare and, therefore, may further help to investigate the RA-CVD association. There are three aims of this review: (1) to summarize the three pathophysiological pathways that link RA to CVD; (2) to identify several traditional and carotid ultrasound image-based CVD risk calculators useful for RA patients, and (3) to understand the role of artificial intelligence in CVD risk assessment in RA patients. Our search strategy involves extensively searches in PubMed and Web of Science databases using search terms associated with CVD risk assessment in RA patients. A total of 120 peer-reviewed articles were screened for this review. We conclude that (a) two of the three pathways directly affect the atherosclerotic process, leading to heart injury, (b) carotid ultrasound image-based calculators have shown superior performance compared with conventional calculators, and (c) AI-based technologies in CVD risk assessment in RA patients are aggressively being adapted for routine practice of RA patients.

Smolen JS, Aletaha D, McInnes IB (2006) Rheumatoid arthritis. Lancet 388(10055):2023–2038. https://doi.org/10.1016/s0140-6736(16)30173-8CrossRef

Cojocaru M, Cojocaru IM, Silosi I, Vrabie CD, Tanasescu R (2010) Extra-articular manifestations in rheumatoid arthritis. Maedica 5(4):286

Cross M, Smith E, Hoy D, Carmona L, Wolfe F, Vos T, Williams B, Gabriel S, Lassere M, Johns N (2014) The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 73(7):1316–1322CrossRef

van Vollenhoven RF (2009) Sex differences in rheumatoid arthritis: more than meets the eye. BMC Med 7(1):12CrossRef

Crowson CS, Liao KP, Davis JM III, Solomon DH, Matteson EL, Knutson KL, Hlatky MA, Gabriel SE (2013) Rheumatoid arthritis and cardiovascular disease. Am Heart J 166(4):622–628 (e621)CrossRef

del Rincón ID, Williams K, Stern MP, Freeman GL, Escalante A (2001) High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 44(12):2737–2745. https://doi.org/10.1002/1529-0131(200112)44:12%3c2737:aid-art460%3e3.0.co;2-%23CrossRef

D’agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB (2008) General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117(6):743–753CrossRef

Conroy R, Pyörälä K, Ae Fitzgerald, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetiere P, Jousilahti P, Keil U (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24(11):987–1003CrossRef

Goff DC, Lloyd-Jones DM, Bennett G, Coady S, D’agostino RB, Gibbons R, Greenland P, Lackland DT, Levy D, O’donnell CJ (2014) 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63(25 Part B):2935–2959CrossRef

10.

Arts E, Popa C, Den Broeder A, Semb A, Toms T, Kitas G, Van Riel P, Fransen J (2014) Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis. Ann Rheum Dis 74:668–74

11.

Crowson CS, Matteson EL, Roger VL, Therneau TM, Gabriel SE (2012) Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis. Am J Cardiol 110(3):420–424CrossRef

12.

Arts E, Popa C, Den Broeder A, Donders R, Sandoo A, Toms T, Rollefstad S, Ikdahl E, Semb A, Kitas G (2015) Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted SCORE algorithms. Ann Rheum Dis 75:674–80

13.

Escalante A, Haas RW, Del Rincón I (2005) Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation. Arch Intern Med 165(14):1624–1629CrossRef

14.

Urruela MA, Suarez-Almazor ME (2012) Lipid paradox in rheumatoid arthritis: changes with rheumatoid arthritis therapies. Curr Rheumatol Rep 14(5):428–437CrossRef

15.

Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJL, Kvien TK, Dougados M, Radner H, Atzeni F, Primdahl J, Södergren A, Wallberg Jonsson S, van Rompay J, Zabalan C, Pedersen TR, Jacobsson L, de Vlam K, Gonzalez-Gay MA, Semb AG, Kitas GD, Smulders YM, Szekanecz Z, Sattar N, Symmons DPM, Nurmohamed MT (2016) EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis. https://doi.org/10.1136/annrheumdis-2016-209775CrossRef

16.

Peters MJ, Symmons D, McCarey D, Dijkmans B, Nicola P, Kvien T, McInnes I, Haentzschel H, Gonzalez-Gay M, Provan S (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69(2):325–331CrossRef

17.

Ridker PM, Buring JE, Rifai N, Cook NR (2007) Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 297(6):611–619CrossRef

18.

Solomon D, Greenberg J, Curtis J, Liu M, Farkouh M, Tsao P, Kremer J, Etzel CJ (2015) Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry Study. Arthritis Rheumatol 67(8):1995–2003CrossRef

19.

Hippisley-Cox J, Coupland C, Brindle P (2017) Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ 357:1–12. https://doi.org/10.1136/bmj.j2099. https://qrisk.org/three

20.

Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A, Brindle P (2008) Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ 336(7659):1475–1482CrossRef

21.

Crowson CS, Rollefstad S, Kitas GD, Van Riel PL, Gabriel SE, Semb AG (2017) Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis. PLoS One 12(3):e0174656CrossRef

22.

Crowson CS, Gabriel SE, Semb AG, van Riel PL, Karpouzas G, Dessein PH, Hitchon C, Pascual-Ramos V, Kitas GD, Arthritis AT-ACCfR (2017) Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries. Rheumatology 56(7):1102–1110CrossRef

23.

Khanna NN, Jamthikar AD, Gupta D, Piga M, Saba L, Carcassi C, Giannopoulos AA, Nicolaides A, Laird JR, Suri HS, Mavrogeni S, Protogerou AD, Sfikakis P, Kitas GD, Suri JS (2019) Rheumatoid arthritis: atherosclerosis imaging and cardiovascular risk assessment using machine and deep learning-based tissue characterization. Curr Atheroscler Rep 21(2):7. https://doi.org/10.1007/s11883-019-0766-xCrossRef

24.

Libby P (2008) Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am J Med 121(10):S21–S31CrossRef

25.

Gasparyan AY, Stavropoulos-Kalinoglou A, Mikhailidis DP, Toms TE, Douglas KM, Kitas GD (2010) The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases. Curr Vasc Pharmacol 8(4):437–449. https://doi.org/10.2174/157016110791330852CrossRef

26.

Skeoch S, Cristinacce PH, Williams H, Pemberton P, Xu D, Sun J, James J, Yuan C, Hatsukami T, Hockings P (2017) Imaging atherosclerosis in rheumatoid arthritis: evidence for increased prevalence, altered phenotype and a link between systemic and localised plaque inflammation. Sci Rep 7(1):1–12CrossRef

27.

Koelemay MJ, Nederkoorn PJ, Reitsma JB, Majoie CB (2004) Systematic review of computed tomographic angiography for assessment of carotid artery disease. Stroke 35(10):2306–2312CrossRef

28.

Boi A, Jamthikar AD, Saba L, Gupta D, Sharma A, Loi B, Laird JR, Khanna NN, Suri JS (2018) A survey on coronary atherosclerotic plaque tissue characterization in intravascular optical coherence tomography. Curr Atheroscler Rep 20(7):33CrossRef

29.

Jamthikar A, Gupta D, Khanna NN, Araki T, Saba L, Nicolaides A, Sharma A, Omerzu T, Suri HS, Gupta A, Mavrogeni S, Turk M, Laird JR, Protogerou AD, Sfikakis P, Kitas GD, Viswanathan V, Pareek G, Miner M, Suri JS (2019) A special report on changing trends in preventive stroke/cardiovascular risk assessment via B-mode ultrasonography. Curr Atheroscler Rep 21(7):25CrossRef

30.

Saba L, Jamthikar A, Gupta D, Khanna NN, Viskovic K, Suri HS, Gupta A, Mavrogeni S, Turk M, Laird JR, Pareek G, Miner M, Sfikakis P, Protogerou A, Kitas GD, Viswanathan V, Nicolaides A, Bhatt D, Suri JS (2019) Global perspective on carotid intima-media thickness and plaque: should the current measurement guidelines be revisited? Int Angiol 38(6):451–465. https://doi.org/10.23736/s0392-9590.19.04267-6CrossRef

31.

Polak JF, Pencina MJ, Pencina KM, O’Donnell CJ, Wolf PA, D’Agostino RB Sr (2011) Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med 365(3):213–221. https://doi.org/10.1056/NEJMoa1012592CrossRef

32.

Lorenz MW, Sitzer M, Markus HS, Bots ML, Rosvall M (2007) Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis-response. Circulation 116(9):318CrossRef

33.

Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER, Najjar SS, Rembold CM, Post WS (2008) Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr 21(2):93–111CrossRef

34.

Johri AM, Nambi V, Naqvi TZ, Feinstein SB, Kim ES, Park MM, Becher H, Sillesen H (2020) Recommendations for the assessment of carotid arterial plaque by ultrasound for the characterization of atherosclerosis and evaluation of cardiovascular risk: from the American Society of Echocardiography. J Am Soc Echocardiogr 33:917–933

35.

del Rincón I, Williams K, Stern MP, Freeman GL, O’leary DH, Escalante A (2003) Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheumatol 48(7):1833–1840CrossRef

36.

Pope JE, Nevskaya T, Barra L, Parraga G (2016) Carotid artery atherosclerosis in patients with active rheumatoid arthritis: predictors of plaque occurrence and progression over 24 weeks. Open Rheumatol J 10:49CrossRef

37.

Kassem E, Ghonimy R, Adel M, El-Sharnoby G (2011) Non traditional risk factors of carotid atherosclerosis in rheumatoid arthritis. Egypt Rheumatol 33(3):113–119CrossRef

38.

Del Rincon I, Polak JF, O’Leary DH, Battafarano DF, Erikson JM, Restrepo JF, Molina E, Escalante A (2015) Systemic inflammation and cardiovascular risk factors predict rapid progression of atherosclerosis in rheumatoid arthritis. Ann Rheum Dis 74(6):1118–1123CrossRef

39.

Carotti M, Salaffi F, Mangiacotti M, Cerioni A, Giuseppetti G, Grassi W (2007) Atherosclerosis in rheumatoid arthtritis: the role of high-resolution B mode ultrasound in the measurement of the arterial intima-media thickness. Reumatismo 59:38–49

40.

Kobayashi H, Giles JT, Polak JF, Blumenthal RS, Leffell MS, Szklo M, Petri M, Gelber AC, Post W, Bathon JM (2010) Increased prevalence of carotid artery atherosclerosis in rheumatoid arthritis is artery-specific. J Rheumatol 37(4):730–739CrossRef

41.

Schott LL, Kao AH, Cunningham A, Wildman RP, Kuller LH, Sutton-Tyrrell K, Wasko MC (2009) Do carotid artery diameters manifest early evidence of atherosclerosis in women with rheumatoid arthritis? J Womens Health (2002) 18(1):21–29. https://doi.org/10.1089/jwh.2008.0797CrossRef

42.

Viswanathan V, Jamthikar AD, Gupta D, Puvvula A, Khanna NN, Saba L, Viskovic K, Mavrogeni S, Turk M, Laird JR, Pareek G, Miner M, Ajuluchukwu JNA, Sfikakis PP, Protogerou A, Kitas GD, Nicolaides A, Sharma A, Suri JS (2020) Integration of eGFR biomarker in image-based CV/stroke risk calculator: a south Asian-Indian diabetes cohort with moderate chronic kidney disease. Int Angiol. https://doi.org/10.23736/s0392-9590.20.04338-2CrossRef

43.

Khanna NN, Jamthikar AD, Gupta D, Araki T, Piga M, Saba L, Carcassi C, Nicolaides A, Laird JR, Suri HS, Gupta A, Mavrogeni S, Protogerou AD, Sfikakis P, Kitas GD, Suri JS (2019) Effect of carotid image-based phenotypes on cardiovascular risk calculator: AECRS1. 0. Med Biol Eng Comput 57(7):1553–1566CrossRef

44.

Khanna NN, Jamthikar AD, Araki T, Gupta D, Piga M, Saba L, Carcassi C, Nicolaides A, Laird JR, Suri HS, Gupta A, Mavrogeni S, Kitas GD, Suri JS (2019) Nonlinear model for the carotid artery disease 10-year risk prediction by fusing conventional cardiovascular factors to carotid ultrasound image phenotypes: a Japanese diabetes cohort study. Echocardiography 36(2):345–361CrossRef

45.

Khanna NN, Jamthikar AD, Gupta D, Nicolaides A, Araki T, Saba L, Cuadrado-Godia E, Sharma A, Omerzu T, Suri HS, Gupta A, Mavrogeni S, Turk M, Laird JR, Protogerou AD, Sfikakis P, Kitas GD, Viswanathan V, Suri JS (2019) Performance evaluation of 10-year ultrasound image-based stroke/cardiovascular (CV) risk calculator by comparing against ten conventional CV risk calculators: a diabetic study. Comput Biol Med 105:125–143CrossRef

46.

Saba L, Biswas M, Kuppili V, Godia EC, Suri HS, Edla DR, Omerzu T, Laird JR, Khanna NN, Mavrogeni S (2019) The present and future of deep learning in radiology. Eur J Radiol 114:10–24

47.

Araki T, Jain PK, Suri HS, Londhe ND, Ikeda N, El-Baz A, Shrivastava VK, Saba L, Nicolaides A, Shafique S (2017) Stroke risk stratification and its validation using ultrasonic Echolucent Carotid Wall plaque morphology: a machine learning paradigm. Comput Biol Med 80:77–96CrossRef

48.

Acharya UR, Swapna G, Sree SV, Molinari F, Gupta S, Bardales RH, Witkowska A, Suri JS (2014) A review on ultrasound-based thyroid cancer tissue characterization and automated classification. Technol Cancer Res Treat 13(4):289–301CrossRef

49.

Saba L, Dey N, Ashour AS, Samanta S, Nath SS, Chakraborty S, Sanches J, Kumar D, Marinho R, Suri JS (2016) Automated stratification of liver disease in ultrasound: an online accurate feature classification paradigm. Comput Methods Progr Biomed 130:118–134. https://doi.org/10.1016/j.cmpb.2016.03.016CrossRef

50.

Tandel G, Biswas M, Kakde OG, Tiwari A, Suri HS, Turk M, Laird JR, Asare CK, Ankrah AA, Khanna NN, Madhusudhan BK, Saba L, Suri JS (2019) A review on a deep learning perspective in brain cancer classification. Cancers 11(1):111. https://doi.org/10.3390/cancers11010111CrossRef

51.

Jamthikar A, Gupta D, Saba L, Khanna NN, Araki T, Viskovic K, Mavrogeni S, Laird JR, Pareek G, Miner M, Sfikakis PP, Protogerou A, Viswanathan V, Sharma A, Nicolaides A, Kitas GD, Suri JS (2020) Cardiovascular/stroke risk predictive calculators: a comparison between statistical and machine learning models. Cardiovasc Diagn Ther 10:921–938

52.

Jamthikar A, Gupta D, Cuadrado-Godia E, Puvvula A, Khanna NN, Saba L, Viskovic K, Mavrogeni S, Turk M, Laird JR, Pareek G, Miner M, Sfikakis PP, Protogerou A, Kitas GD, Shankar C, Nicolaides A, Viswanathan V, Sharma A, Suri JS (2020) Ultrasound-based stroke/cardiovascular risk stratification using Framingham Risk Score and ASCVD Risk Score based on “Integrated Vascular Age” instead of “Chronological Age”: a multi-ethnic study of Asian Indian, Caucasian, and Japanese cohorts. Cardiovasc Diagn Ther 10:939–954

53.

McClure P, Elnakib A, El-Ghar MA, Khalifa F, Soliman A, El-Diasty T, Suri JS, Elmaghraby A, El-Baz A (2014) In-vitro and in vivo diagnostic techniques for prostate cancer: a review. J Biomed Nanotechnol 10(10):2747–2777CrossRef

54.

Jamthikar A, Gupta D, Khanna NN, Saba L, Araki T, Viskovic K, Suri HS, Gupta A, Mavrogeni S, Turk M, Laird JR, Pareek G, Miner M, Sfikakis PP, Protogerou A, Kitas GD, Viswanathan V, Nicolaides A, Bhatt DL, Suri JS (2019) A low-cost machine learning-based cardiovascular/stroke risk assessment system: integration of conventional factors with image phenotypes. Cardiovasc Diagn Ther 9(5):420–430. https://doi.org/10.21037/cdt.2019.09.03CrossRef

55.

Kakadiaris IA, Vrigkas M, Yen AA, Kuznetsova T, Budoff M, Naghavi M (2018) Machine learning outperforms ACC/AHA CVD risk calculator in MESA. J Am Heart Assoc 7(22):e009476CrossRef

56.

Weng SF, Reps J, Kai J, Garibaldi JM, Qureshi N (2017) Can machine-learning improve cardiovascular risk prediction using routine clinical data? PLoS One 12(4):e0174944CrossRef

57.

Zhou S-M, Fernandez-Gutierrez F, Kennedy J, Cooksey R, Atkinson M, Denaxas S, Siebert S, Dixon WG, O’Neill TW, Choy E, Sudlow C, Follow-up UKB, Outcomes G, Brophy S (2016) Defining disease phenotypes in primary care electronic health records by a machine learning approach: a case study in identifying rheumatoid arthritis. PLoS One 11(5):e0154515. https://doi.org/10.1371/journal.pone.0154515CrossRef

58.

Lin C, Karlson EW, Canhao H, Miller TA, Dligach D, Chen PJ, Perez RNG, Shen Y, Weinblatt ME, Shadick NA, Plenge RM, Savova GK (2013) Automatic prediction of rheumatoid arthritis disease activity from the electronic medical records. PLoS One 8(8):e69932. https://doi.org/10.1371/journal.pone.0069932CrossRef

59.

Orange DE, Agius P, DiCarlo EF, Robine N, Geiger H, Szymonifka J, McNamara M, Cummings R, Andersen KM, Mirza S, Figgie M, Ivashkiv LB, Pernis AB, Jiang CS, Frank MO, Darnell RB, Lingampali N, Robinson WH, Gravallese E, Arthritis tAMPiR, Network L, Bykerk VP, Goodman SM, Donlin LT (2018) Identification of three rheumatoid arthritis disease subtypes by machine learning integration of synovial histologic features and RNA sequencing data. Arthritis Rheumatol 70(5):690–701. https://doi.org/10.1002/art.40428CrossRef

60.

Lezcano-Valverde JM, Salazar F, León L, Toledano E, Jover JA, Fernandez-Gutierrez B, Soudah E, González-Álvaro I, Abasolo L, Rodriguez-Rodriguez L (2017) Development and validation of a multivariate predictive model for rheumatoid arthritis mortality using a machine learning approach. Sci Rep 7(1):10189. https://doi.org/10.1038/s41598-017-10558-wCrossRef

61.

Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31(11):1409CrossRef

62.

Sattar N, McCarey DW, Capell H, McInnes IB (2003) Explaining how “high-grade” systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 108(24):2957–2963CrossRef

63.

Munzel T, Heitzer T, Harrison DG (1997) The physiology and pathophysiology of the nitric oxide/superoxide system. Herz 22(3):158–172CrossRef

64.

Safar ME, Asmar R, Benetos A, Blacher J, Boutouyrie P, Lacolley P, Laurent S, London G, Pannier B, Protogerou A (2018) Interaction between hypertension and arterial stiffness: an expert reappraisal. Hypertension 72(4):796–805CrossRef

65.

Yuri Gasparyan A, Ayvazyan L, Cocco G, Kitas DG (2012) Adverse cardiovascular effects of antirheumatic drugs: implications for clinical practice and research. Curr Pharm Des 18(11):1543–1555CrossRef

66.

Panoulas VF, Metsios GS, Pace A, John H, Treharne G, Banks M, Kitas GD (2008) Hypertension in rheumatoid arthritis. Rheumatology 47(9):1286–1298CrossRef

67.

Van Halm V, Nielen M, Nurmohamed M, Van Schaardenburg D, Reesink H, Voskuyl A, Twisk J, Van de Stadt R, De Koning M, Habibuw M (2007) Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis. Ann Rheum Dis 66(2):184–188CrossRef

68.

Toms ET, Symmons PD, Kitas DG (2010) Dyslipidaemia in rheumatoid arthritis: the role of inflammation, drugs, lifestyle and genetic factors. Curr Vasc Pharmacol 8(3):301–326CrossRef

69.

Toms TE, Panoulas VF, Douglas KM, Nightingale P, Smith JP, Griffiths H, Sattar N, Symmons DP, Kitas GD (2011) Are lipid ratios less susceptible to change with systemic inflammation than individual lipid components in patients with rheumatoid arthritis? Angiology 62(2):167–175. https://doi.org/10.1177/0003319710373749CrossRef

70.

Summers GD, Metsios GS, Stavropoulos-Kalinoglou A, Kitas GD (2010) Rheumatoid cachexia and cardiovascular disease. Nat Rev Rheumatol 6(8):445CrossRef

71.

Rall L, Roubenoff R (2004) Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions. Rheumatology 43(10):1219–1223CrossRef

72.

Guttridge DC, Mayo MW, Madrid LV, Wang C-Y, Baldwin AS Jr (2000) NF-κB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 289(5488):2363–2366CrossRef

73.

Lemmey AB (2015) Rheumatoid cachexia: the undiagnosed, untreated key to restoring physical function in rheumatoid arthritis patients? Rheumatology 55(7):1149–1150. https://doi.org/10.1093/rheumatology/kev412CrossRef

74.

Elkan A-C, Engvall I-L, Cederholm T, Hafström I (2009) Rheumatoid cachexia, central obesity and malnutrition in patients with low-active rheumatoid arthritis: feasibility of anthropometry, Mini Nutritional Assessment and body composition techniques. Eur J Nutr 48(5):315–322CrossRef

75.

Stavropoulos-Kalinoglou A, Metsios GS, Panoulas VF, Nevill AM, Jamurtas AZ, Koutedakis Y, Kitas GD (2009) Underweight and obese states both associate with worse disease activity and physical function in patients with established rheumatoid arthritis. Clin Rheumatol 28(4):439–444CrossRef

76.

Da Cunha V, Brenol C, Brenol J, Fuchs S, Arlindo E, Melo I, Machado C, de Castro Chaves H Jr, Xavier R (2012) Metabolic syndrome prevalence is increased in rheumatoid arthritis patients and is associated with disease activity. Scand J Rheumatol 41(3):186–191CrossRef

77.

Shahin D, Eltoraby E, Mesbah A, Houssen M (2010) Insulin resistance in early untreated rheumatoid arthritis patients. Clin Biochem 43(7–8):661–665CrossRef

78.

Natali A, Toschi E, Baldeweg S, Ciociaro D, Favilla S, Saccà L, Ferrannini E (2006) Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes. Diabetes 55(4):1133–1140. https://doi.org/10.2337/diabetes.55.04.06.db05-1076CrossRef

79.

Pamuk ON, Unlü E, Cakir N (2006) Role of insulin resistance in increased frequency of atherosclerosis detected by carotid ultrasonography in rheumatoid arthritis. J Rheumatol 33(12):2447–2452

80.

Libby P (2006) Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr 83(2):456S–460SCrossRef

81.

Duerden M, O’Flynn N Qureshi N (2015) Cardiovascular risk assessment and lipid modification: NICE guideline. British J Gen Pract 65(636):378–380

82.

Anderson TJ, Grégoire J, Pearson GJ, Barry AR, Couture P, Dawes M, Francis GA, Genest J, Grover S, Gupta M, Hegele RA, Lau DC, Leiter LA, Lonn E, Mancini GBJ, McPherson R, Ngui D, Poirier P, Sievenpiper JL, Stone JA, Thanassoulis G, Ward R (2016) 2016 Canadian Cardiovascular Society Guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol 32(11):1263–1282. https://doi.org/10.1016/j.cjca.2016.07.510

83.

Mendis S, Lindholm LH, Mancia G, Whitworth J, Alderman M, Lim S, Heagerty T (2007) World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countries. J Hypertens 25(8):1578–1582CrossRef

84.

Lagrand WK, Visser CA, Hermens WT, Niessen HWM, Verheugt FWA, Wolbink G-J, Hack CE (1999) C-reactive protein as a cardiovascular risk factor. Circulation 100(1):96–102. https://doi.org/10.1161/01.CIR.100.1.96CrossRef

85.

Rajagopalan V, Alemao E, Kawabata H, Solomon D (2014) SAT0069 performance of the Framingham Cardiovascular risk prediction model with and without C-reactive protein or erythrocyte sedimentation rate in RA: analysis of US electronic medical records database. Ann Rheum Dis 73(Suppl 2):615CrossRef

86.

van der Heijde D, Ramiro S, Landewé R, Baraliakos X, Van den Bosch F, Sepriano A, Regel A, Ciurea A, Dagfinrud H, Dougados M (2017) 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis 76(6):978–991CrossRef

87.

Curtis J, Xie F, Crowson C, Mabey B, Flake D, Bamford R, Chin C, Sasso E, Hitraya E, Ben-Shachar R (2020) FRI0553 Development and validation of a biomarker-based cardiovascular risk prediction score in rheumatoid arthritis. BMJ 71:2350

88.

Wahlin B, Innala L, Magnusson S, Möller B, Smedby T, Rantapää-Dahlqvist S, Wållberg-Jonsson S (2019) Performance of the expanded cardiovascular risk prediction score for rheumatoid arthritis is not superior to the ACC/AHA Risk calculator. J Rheumatol 46(2):130–137CrossRef

89.

Corrales A, Dessein PH, Tsang L, Pina T, Blanco R, Gonzalez-Juanatey C, Llorca J, Gonzalez-Gay MA (2015) Carotid artery plaque in women with rheumatoid arthritis and low estimated cardiovascular disease risk: a cross-sectional study. Arthritis Res Ther 17(1):55CrossRef

90.

Fent GJ, Greenwood JP, Plein S, Buch MH (2017) The role of non-invasive cardiovascular imaging in the assessment of cardiovascular risk in rheumatoid arthritis: where we are and where we need to be. Ann Rheum Dis 76(7):1169CrossRef

91.

Yoon HE, Kim Y, Kim SD, Oh JK, Chung Y-A, Shin SJ, Yang CW, Seo SM (2018) A pilot trial to examine the changes in carotid arterial inflammation in renal transplant recipients as assessed by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography computed tomography (PET/CT). Ann Transplant 23:412–421. https://doi.org/10.12659/AOT.909212CrossRef

92.

Viswanathan V, Jamthikar AD, Gupta D, Shanu N, Puvvula A, Khanna NN, Saba L, Omerzum T, Viskovic K, Mavrogeni S, Turk M, Laird JR, Pareek G, Miner M, Sfikakis PP, Protogerou A, Kitas GD, Joshi SCS, Fiscian H, Folson AA, Wu DH, Ruzsa Z, Nicolaides A, Sharma A, Bhatt DL, Suri JS (2020) Low-cost preventive screening using carotid ultrasound in patients with diabetes. Front Biosci (Landmark Ed) 25:1132–1171CrossRef

93.

Ristić GG, Lepić T, Glišić B, Stanisavljević D, Vojvodić D, Petronijević M, Stefanović D (2010) Rheumatoid arthritis is an independent risk factor for increased carotid intima-media thickness: impact of anti-inflammatory treatment. Rheumatology 49(6):1076–1081CrossRef

94.

Viswanathan V, Jamthikar AD, Gupta D, Puvvula A, Khanna NN, Saba L, Viskovic K, Mavrogeni S, Laird JR, Pareek G, Miner M, Sfikakis PP, Protogerou A, Kitas GD, Nicolaides A, Sharma A, Suri JS (2020) Does the carotid bulb offer a better 10-year CVD/stroke risk assessment compared with the common carotid artery?: a 1516 ultrasound scan study. Angiology. https://doi.org/10.1177/0003319720941730

95.

Lind L, Gigante B, Borne Y, Mälarstig A, Sundström J, Ärnlöv J, Ingelsson E, Baldassarre D, Tremoli E, Veglia F (2020) The plasma protein profile and cardiovascular risk differ between intima-media thickness of the common carotid artery and the bulb: a meta-analysis and a longitudinal evaluation. Atherosclerosis 295:25–30

96.

Gregg S, Li TY, Hétu M-F, Pang SC, Ewart P, Johri AM (2018) Relationship between carotid artery atherosclerosis and bulb geometry. Int J Cardiovasc Imaging 34(7):1081–1090CrossRef

97.

Okazaki S, Sakaguchi M, Miwa K, Furukado S, Yamagami H, Yagita Y, Mochizuki H, Kitagawa K (2014) Association of interleukin-6 with the progression of carotid atherosclerosis: a 9-year follow-up study. Stroke 45(10):2924–2929. https://doi.org/10.1161/strokeaha.114.005991CrossRef

98.

Yayan J (2012) Erythrocyte sedimentation rate as a marker for coronary heart disease. Vasc Health Risk Manag 8:219CrossRef

99.

Andresdottir MB, Sigfusson N, Sigvaldason H, Gudnason V (2003) Erythrocyte sedimentation rate, an independent predictor of coronary heart disease in men and women: the Reykjavik Study. Am J Epidemiol 158(9):844–851. https://doi.org/10.1093/aje/kwg222CrossRef

100.

Natali A, L’Abbate A, Ferrannini E (2003) Erythrocyte sedimentation rate, coronary atherosclerosis, and cardiac mortality. Eur Heart J 24(7):639–648CrossRef

101.

Xie D, Hu D, Zhang Q, Sun Y, Li J, Zhang Y (2016) Increased high-sensitivity C-reactive protein, erythrocyte sedimentation rate and lactic acid in stroke patients with internal carotid artery occlusion. Arch Med Sci 12(3):546–551. https://doi.org/10.5114/aoms.2014.47879CrossRef

102.

Eftekhaari TE (2012) ESR rate can be a marker for coronary artery disease. Vasc Health Risk Manag 8:669–670. https://doi.org/10.2147/VHRM.S39006CrossRef

103.

Sander D, Schulze-Horn C, Bickel H, Gnahn H, Bartels E, Conrad B (2006) Combined effects of hemoglobin A1c and C-reactive protein on the progression of subclinical carotid atherosclerosis: the INVADE study. Stroke 37(2):351–357CrossRef

104.

van der Meer IM, de Maat MP, Hak AE, Kiliaan AJ, Del Sol AI, van der Kuip DA, Nijhuis RL, Hofman A, Witteman JC (2002) C-reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree: the Rotterdam Study. Stroke 33(12):2750–2755CrossRef

105.

Toprak A, Kandavar R, Toprak D, Chen W, Srinivasan S, Xu JH, Anwar A, Berenson GS (2011) C-reactive protein is an independent predictor for carotid artery intima-media thickness progression in asymptomatic younger adults (from the Bogalusa Heart Study). BMC Cardiovasc Disord 11(1):78CrossRef

106.

Nambi V, Chambless L, Folsom AR, He M, Hu Y, Mosley T, Volcik K, Boerwinkle E, Ballantyne CM (2010) Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. J Am Coll Cardiol 55(15):1600–1607CrossRef

107.

Biswas M, Kuppili V, Saba L, Edla DR, Suri HS, Cuadrado-Godia E, Laird JR, Marinhoe RT, Sanches JM, Nicolaides A (2019) State-of-the-art review on deep learning in medical imaging. Front Biosci (Landmark edition) 24:392–426CrossRef

108.

El-Baz A, Suri JS (2011) Lung imaging and computer aided diagnosis. CRC Press, Boca Raton

109.

Li L, Qin L, Xu Z, Yin Y, Wang X, Kong B, Bai J, Lu Y, Fang Z, Song Q (2020) Artificial intelligence distinguishes COVID-19 from community acquired pneumonia on chest CT. Radiology 296:65–72

110.

Ilyas M, Rehman H, Naït-Ali A (2020) Detection of Covid-19 from chest X-ray images using artificial intelligence: an early review. arXiv preprint arXiv:200405436

111.

Biswas M, Kuppili V, Saba L, Edla DR, Suri HS, Sharma A, Cuadrado-Godia E, Laird JR, Nicolaides A, Suri JS (2019) Deep learning fully convolution network for lumen characterization in diabetic patients using carotid ultrasound: a tool for stroke risk. Med Biol Eng Comput 57(2):543–564CrossRef

112.

Skandha S, Gupta S, Saba L, Koppula V, Suri JS (2020) Ultrasound-based carotid plaque tissue risk stratification using 3-D optimized artificial intelligence paradigm: a cardiovascular/stroke application: atheromatic 2.0. Comput Biol Med. https://doi.org/10.1016/j.compbiomed.2020.103958

113.

Svanteson M, Rollefstad S, Kløw NE, Hisdal J, Ikdahl E, Semb AG, Haig Y (2017) Associations between coronary and carotid artery atherosclerosis in patients with inflammatory joint diseases. RMD Open 3(2):e000544. https://doi.org/10.1136/rmdopen-2017-000544CrossRef

114.

Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350(14):1387–1397. https://doi.org/10.1056/NEJMoa032804CrossRef

115.

Timmer JR, Ottervanger JP, Hoorntje JC, DeBoer MJ, Suryapranata H, Van’t Hof AW, Zijlstra F, Group TZMIS (2005) Prognostic value of erythrocyte sedimentation rate in ST segment elevation myocardial infarction: interaction with hyperglycaemia. J Intern Med 257(5):423–429. https://doi.org/10.1111/j.1365-2796.2005.01478.xCrossRef

116.

Gastounioti A, Makrodimitris S, Golemati S, Kadoglou NP, Liapis CD, Nikita KS (2015) A novel computerized tool to stratify risk in carotid atherosclerosis using kinematic features of the arterial wall. IEEE J Biomed Health Inform 19(3):1137–1145

117.

Unnikrishnan P, Kumar DK, Poosapadi Arjunan S, Kumar H, Mitchell P, Kawasaki R (2016) Development of health parameter model for risk prediction of CVD using SVM. Comput Math Methods Med 2016:1–7

118.

Ambale-Venkatesh B, Wu CO, Liu K, Hundley W, McClelland RL, Gomes AS, Folsom AR, Shea S, Guallar E, Bluemke DA (2017) Cardiovascular event prediction by machine learning: the Multi-Ethnic Study of Atherosclerosis. Cir Res CIRCRESAHA 121:1092–1101

119.

Banchhor SK, Londhe ND, Araki T, Saba L, Radeva P, Laird JR, Suri JS (2017) Wall-based measurement features provides an improved IVUS coronary artery risk assessment when fused with plaque texture-based features during machine learning paradigm. Comput Biol Med 91:198–212CrossRef

120.

Jamthikar A, Gupta D, Khanna NN, Saba L, Laird JR, Suri JS (2020) Cardiovascular/stroke risk prevention: a new machine learning framework integrating carotid ultrasound image-based phenotypes and its harmonics with conventional risk factors. Indian Heart J. https://doi.org/10.1016/j.ihj.2020.06.004CrossRef

Titel: Cardiovascular risk assessment in patients with rheumatoid arthritis using carotid ultrasound B-mode imaging
verfasst von: Ankush D. Jamthikar
Deep Gupta
Anudeep Puvvula
Amer M. Johri
Narendra N. Khanna
Luca Saba
Sophie Mavrogeni
John R. Laird
Gyan Pareek
Martin Miner
Petros P. Sfikakis
Athanasios Protogerou
George D. Kitas
Raghu Kolluri
Aditya M. Sharma
Vijay Viswanathan
Vijay S. Rathore
Jasjit S. Suri
Publikationsdatum: 28.08.2020
Verlag: Springer Berlin Heidelberg
Erschienen in: Rheumatology International / Ausgabe 12/2020
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-020-04691-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Cardiovascular risk assessment in patients with rheumatoid arthritis using carotid ultrasound B-mode imaging

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

Vorsicht, erhöhte Blutungsgefahr nach PCI!

Erhöhte Mortalität bei postpartalem Brustkrebs

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2020

Acknowledgement to referees

Comparing quality and readability of online English language information to patient use and perspectives for common rheumatologic conditions

High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study

Subclinical atherosclerosis in systemic sclerosis and rheumatoid arthritis: a comparative matched-cohort study

Adaptation and validation of the Rheumatoid Arthritis Quality of Life (RAQoL) questionnaire for use in Bulgaria

Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

Vorsicht, erhöhte Blutungsgefahr nach PCI!

Erhöhte Mortalität bei postpartalem Brustkrebs

Update Innere Medizin